Literature DB >> 21922276

Silencing of c-Met by RNA interference inhibits the survival, proliferation, and invasion of nasopharyngeal carcinoma cells.

Yuncheng Li1, Sulin Zhang, Zhengang Tang, Jian Chen, Weijia Kong.   

Abstract

c-Met is a tyrosine kinase receptor that mediates pleiotropic cellular responses following its activation by hepatocyte growth factor. The overexpression of c-Met in nasopharyngeal carcinoma (NPC) has been described recently, but the functional role of c-Met in NPC remains incompletely understood. This study aimed to investigate the potential mechanism by which c-Met contributes to the tumorigenesis of NPC. In the present study, by using RNA interference we silenced the expression of c-Met in CNE-2 cells, a poorly differentiated NPC cell line. Our in vitro studies showed that shRNA-mediated depletion of c-Met resulted in the suppression of proliferation, migration, and invasion, as well as an increase in the apoptosis of CNE-2 cells. Moreover, in xenograft nude mice we demonstrated that the depletion of c-Met resulted in reduced tumor growth and increased apoptosis in xenografts. Taken together, these results suggest that c-Met plays an oncogenic role in the development of NPC and reveal it as a potential novel therapeutic target for NPC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21922276     DOI: 10.1007/s13277-011-0225-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  32 in total

1.  Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death.

Authors:  V W Y Lui; E Y L Wong; K Ho; P K S Ng; C P Y Lau; S K W Tsui; C-M Tsang; S-W Tsao; S H Cheng; M H L Ng; Y K Ng; E K Y Lam; B Hong; K W Lo; T S K Mok; A T C Chan; G B Mills
Journal:  Oncogene       Date:  2010-11-08       Impact factor: 9.867

Review 2.  Hepatocyte growth factor/scatter factor-Met signaling in tumorigenicity and invasion/metastasis.

Authors:  M Jeffers; S Rong; G F Vande Woude
Journal:  J Mol Med (Berl)       Date:  1996-09       Impact factor: 4.599

3.  Frequent amplification of the c-met gene in scirrhous type stomach cancer.

Authors:  H Kuniyasu; W Yasui; Y Kitadai; H Yokozaki; H Ito; E Tahara
Journal:  Biochem Biophys Res Commun       Date:  1992-11-30       Impact factor: 3.575

4.  Hepatocyte growth factor enhances proteolysis and invasiveness of human nasopharyngeal cancer cells through activation of PI3K and JNK.

Authors:  Hong Yan Zhou; Kai Fung Wan; Carman K M Ip; Chris K C Wong; Nai Ki Mak; Kwok Wai Lo; Alice S T Wong
Journal:  FEBS Lett       Date:  2008-09-18       Impact factor: 4.124

5.  Down-regulation of c-Met expression inhibits human HCC cells growth and invasion by RNA interference.

Authors:  Bin Xie; Renxin Xing; Ping Chen; Yuanbin Gou; Shan Li; Jing Xiao; Jiahong Dong
Journal:  J Surg Res       Date:  2009-05-19       Impact factor: 2.192

Review 6.  Drug development of MET inhibitors: targeting oncogene addiction and expedience.

Authors:  Paolo M Comoglio; Silvia Giordano; Livio Trusolino
Journal:  Nat Rev Drug Discov       Date:  2008-06       Impact factor: 84.694

7.  Inhibition of T24 human bladder carcinoma cell migration by RNA interference suppressing the expression of HD-PTP.

Authors:  Massimo Mariotti; Sara Castiglioni; Jeanette A M Maier
Journal:  Cancer Lett       Date:  2008-10-02       Impact factor: 8.679

8.  A protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US Caucasians.

Authors:  R D Burt; T L Vaughan; B Nisperos; M Swanson; M Berwick
Journal:  Int J Cancer       Date:  1994-02-15       Impact factor: 7.396

Review 9.  Nasopharyngeal carcinomas: an update.

Authors:  J-P Spano; P Busson; D Atlan; J Bourhis; J-P Pignon; C Esteban; J-P Armand
Journal:  Eur J Cancer       Date:  2003-10       Impact factor: 9.162

10.  Cripto-1 overexpression is involved in the tumorigenesis of nasopharyngeal carcinoma.

Authors:  Zhengrong Wu; Gang Li; Lirong Wu; Desheng Weng; Xiangping Li; Kaitai Yao
Journal:  BMC Cancer       Date:  2009-09-06       Impact factor: 4.430

View more
  10 in total

1.  Increased hepatocyte growth factor and c-Met receptor expression in nasopharyngeal carcinoma.

Authors:  Tian Luan; Yang Yu
Journal:  Int J Clin Exp Med       Date:  2014-12-15

2.  Knockdown of c-MET induced apoptosis in ABCB1-overexpressed multidrug-resistance cancer cell lines.

Authors:  T-H Hung; Y-H Li; C-P Tseng; Y-W Lan; S-C Hsu; Y-H Chen; T-T Huang; H-C Lai; C-M Chen; K-B Choo; K-Y Chong
Journal:  Cancer Gene Ther       Date:  2015-04-24       Impact factor: 5.987

3.  Regulation of MET-mediated proliferation of thyroid carcinoma cells by miR-449b.

Authors:  Lei Chen; Lei Xu; Gang Wang
Journal:  Tumour Biol       Date:  2015-06-06

4.  MiR-34c suppresses tumor growth and metastasis in nasopharyngeal carcinoma by targeting MET.

Authors:  Y-Q Li; X-Y Ren; Q-M He; Y-F Xu; X-R Tang; Y Sun; M-S Zeng; T-B Kang; N Liu; J Ma
Journal:  Cell Death Dis       Date:  2015-01-22       Impact factor: 8.469

Review 5.  [Research progress of HGF/MET signaling pathway in EGFR-TKI resistance 
in non-small cell lung cancer].

Authors:  Shilong Song; Minghong Bi
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-10-20

6.  Anti-neoplastic Effect of Ginkgolide C through Modulating c-Met Phosphorylation in Hepatocellular Carcinoma Cells.

Authors:  Min Hee Yang; Seung Ho Baek; Jae-Young Um; Kwang Seok Ahn
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

7.  LINC00839 knockdown restrains the metastatic behavior of nasopharyngeal carcinoma by sponging miR-454-3p.

Authors:  Feng Ying Zhang; Xia Li; Ting Ting Huang; Mei Ling Xiang; Lin Lin Sun; Zhao Lan Sun
Journal:  Aging (Albany NY)       Date:  2021-12-29       Impact factor: 5.682

8.  MACC1 down-regulation inhibits proliferation and tumourigenicity of nasopharyngeal carcinoma cells through Akt/β-catenin signaling pathway.

Authors:  Fengjiao Meng; Hui Li; Huijuan Shi; Qingxu Yang; Fenfen Zhang; Yang Yang; Lili Kang; Tiantian Zhen; Sujuan Dai; Yu Dong; Anjia Han
Journal:  PLoS One       Date:  2013-04-03       Impact factor: 3.240

9.  Met degradation by SAIT301, a Met monoclonal antibody, reduces the invasion and migration of nasopharyngeal cancer cells via inhibition of EGR-1 expression.

Authors:  B-S Lee; S Kang; K-A Kim; Y-J Song; K H Cheong; H-Y Cha; C-H Kim
Journal:  Cell Death Dis       Date:  2014-04-10       Impact factor: 8.469

10.  Long Noncoding RNA HOXA11-AS Modulates the Resistance of Nasopharyngeal Carcinoma Cells to Cisplatin via miR-454-3p/c-Met.

Authors:  Feng-Jie Lin; Xian-Dong Lin; Lu-Ying Xu; Shi-Quan Zhu
Journal:  Mol Cells       Date:  2020-10-31       Impact factor: 5.034

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.